We are live on
!
Find out more
SIP
Stoneridge Investment Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
7.66%
This Fund
S&P 500
This Quarter
Est. Return
-13.75%
1 Year Est. Return
+7.66%
3 Year Est. Return
+26.37%
5 Year Est. Return
+15.44%
10 Year Est. Return
+55.31%
AUM
$713M
AUM Growth
-$97.1M
(-12%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
2.2%
Top 10 Holdings %
Top 10 Hldgs %
21.39%
Holding
340
New
71
Increased
82
Reduced
98
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$22.8M |
| 2 |
Kohl's
KSS
|
+$17.8M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$13.5M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$12.2M |
| 5 |
STJ
St Jude Medical
STJ
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$20.9M |
| 2 |
Royal Caribbean
RCL
|
+$19.5M |
| 3 |
Lowe's Companies
LOW
|
+$14.5M |
| 4 |
Microsoft
MSFT
|
+$14.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.4% |
| 2 | Technology | 15.43% |
| 3 | Healthcare | 14.56% |
| 4 | Consumer Discretionary | 14.04% |
| 5 | Industrials | 10.63% |
Similar funds
DW
PF
AFW
RC
CPW
SMA
LDNAM
MFF
Stoneridge Investment Partners's Q3 2015 Portfolio in Review
As of Q3 2015, Stoneridge Investment Partners held 340 positions worth $713M, down 12% from $810M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Stoneridge Investment Partners's Q3 2015 filing shows 71 new, 82 increased, 98 reduced and 62 closed positions. Its largest new stake was Viatris: 408,857 shares worth $16.5M. The largest sale was Johnson & Johnson, an estimated $20.9M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Stoneridge Investment Partners's largest Q3 2015 buy was Viatris: 408,857 shares worth $16.5M.
- Stoneridge Investment Partners added most to Kohl's in Q3 2015, an estimated $17.8M increase.
- Stoneridge Investment Partners's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $20.9M.
- Stoneridge Investment Partners fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $8.7M.
- Stoneridge Investment Partners's ten largest holdings make up 21% of its $713M portfolio in Q3 2015.
- Stoneridge Investment Partners opened 71 new positions and closed 62 in Q3 2015.
- Stoneridge Investment Partners's portfolio value fell 12% quarter-over-quarter to $713M.
Based on Stoneridge Investment Partners's 13F filing for Q3 2015, filed 26 Oct 2015.